Banner Portal
Immunodeficiency of IgG immunoglobulins subclass 3
PDF (Português (Brasil))

Keywords

Immunodeficiency
Infections
Immunity
IgG3 Deficiency

How to Cite

CHIARADIA, Flávia Dufloth; RICHTER, Lara; TAVARES, Letícia; COSTA, Daiane Cobianchi da; BUENO, Edneia Casagranda; GERALDO, Alexandre. Immunodeficiency of IgG immunoglobulins subclass 3: case report. Serviço Social e Saúde, Campinas, SP, v. 21, n. 00, p. e022005, 2022. DOI: 10.20396/sss.v21i00.8665213. Disponível em: https://periodicos.sbu.unicamp.br/ojs/index.php/sss/article/view/8665213. Acesso em: 17 jul. 2024.

Abstract

Immunodeficiencies, primary or congenital, are a group of pathologies with very diverse etiopathogenesis, in which there is a quantitative and/or qualitative deficit in the immune system. This study aims to carry out a case report of IgG subclass 3 immunodeficiency. During childhood, the patient had severe respiratory allergies and was frequently hospitalized for pneumonia. In the adolescence, she manifested infections that evolved quickly to more severe conditions, mainly in the respiratory tract and urinary system. In adulthood, she developed bacterial pneumonia after flu symptoms. The suspicions that recurrent infections could be indications of another pathology started when the patient noticed that, in addition to her infections developing in a severe way, she had no apparent immune response to them. She reported having impaired her social and personal life until diagnosis and proper treatment. The initial treatment consisted of corticosteroid therapy in associoation to continuos use of sulfamethoxazole and trimethoprim, with no resolution, added to vaccines administration, which had little seroconversion. Due to the inefficiency, the treatment with immunoglobulin infusion was started, which showed positive results in the patient and continues until the present. This case report highlights the social impact caused by the clinical complications prior to the diagnosis, the significant improvement in the quality of life after the adequate treatment, as well as the difficulty in diagnosing the disease and the lack of qualified professionals for this.

https://doi.org/10.20396/sss.v21i00.8665213
PDF (Português (Brasil))

References

ABBAS, Abul K.; LICHTMAN, Andrew H.; PILLAI, Shiv. Imunidade na defesa e doença. In: ABBAS, Abul K. et al. Imunologia Celular e Molecular. 6. ed. Brasil: Elsevier, 2008. Cap. 5. p. 471-472.

AZIZI, G.; ABOLHASSANI, H.; ASGARDOON, Mohammad H.; ALINIA, T.; YAZDANI, R.; MOHAMMADI, J.; REZAEI, N.; OCHS, Hans D.; AGHAMOHAMMADI A. Autoimmunity in common variable immunodeficiency: epidemiology, pathophysiology and management. Expert Review Of Clinical Immunology, [s.l.], v. 13, n. 2, p.101-115, 16 set. 2016. Informa UK Limited. http://dx.doi.org/10.1080/1744666x.2016.1224664.

AZIZI, G.; ZIAEE, V.; TAVAKOL, M.; ALINIA, T.; YAZDAI, R.; MOHAMMADI, H.; ABOLHASSANI, H.; AGHAMOHAMMADI, A. Approach to the Management of Autoimmunity in Primary Immunodeficiency. Scandinavian Journal Of Immunology, [s.l.], v. 85, n. 1, p.13-29, jan. 2017. Wiley. http://dx.doi.org/10.1111/sji.12506.

BERGER, Melvin; PINCIARO, Paul J. Safety, Efficacy, and Pharmacokinetics of Flebogamma®5% [Immune Globulin Intravenous (Human)] for Replacement Therapy in Primary Immunodeficiency Diseases. Journal Of Clinical Immunology, [S.L.], v. 24, n. 4, p. 389-396, jul. 2004. Springer Science and Business Media LLC. http://dx.doi.org/10.1023/b:joci.0000029108.18995.61

BICHUETTI-SILVA, Danielli C.; et al. Reações adversas à imunoglobulina humana endovenosa no tratamento de pacientes com imunodeficiência primária. Brazilian Journal Of Allergy And Immunology (Bjai), [S.L.], v. 1, n. 6, p. 328-334, 2013. GN1 Genesis Network. http://dx.doi.org/10.5935/2318-5015.20130048 .

BJÖRKANDER, Janne; BERTERÖ, Carina M. Advoy.com™ ajuda a melhorar a qualidade de vida dos pacientes portadores de transtornos de imunodeficiência primária? Revista Eletrônica de Comunicação Informação Inovação & Saúde, [S.L.], v. 4, n. 2, p. 3-8, 30 jun. 2010. Fundação Oswaldo Cruz. http://dx.doi.org/10.3395/reciis.v4i2.251pt.

BONILLA, Francisco A.; et al. Practice parameter for the diagnosis and management of primary immunodeficiency. Journal Of Allergy And Clinical Immunology, [s.l.], v. 136, n. 5, p.1186-1205, nov. 2015. Elsevier BV. http://dx.doi.org/10.1016/j.jaci.2015.04.049.

BOYLE, John M.; BUCKLEY, Rebecca H. Population Prevalence of Diagnosed Primary Immunodeficiency Diseases in the United States. Journal Of Clinical Immunology, [s.l.], v. 27, n. 5, p.497-502, 19 jun. 2007. Springer Nature. http://dx.doi.org/10.1007/s10875-007-9103-1.

BRASIL. Ministério da saúde. Doenças raras: o que são, causas, tratamento, diagnóstico e prevenção. Disponível em: <http://www.saude.gov.br/saude-de-a-z/doencas-raras>. Acesso em: 3 fev. 2020.

BRASIL. Ministério da Saúde. Gabinete do Ministro. Portaria nº 199, de 30 de janeiro de 2014. Institui a Política Nacional de Atenção Integral à Pessoas com Doenças Raras, aprova as Diretrizes para Atenção Integral às Pessoas com Doenças Raras no âmbito do Sistema Único de Saúde (SUS) e institui incentivos financeiros de custeio. Diário Oficial da União, Brasília, 2014.

CARVALHO, Beatriz Tavares Costa et al. I Consenso brasileiro sobre o uso de imunoglobulina humana em pacientes com imunodeficiências primárias. Revista Brasileira de Alergia e Imunopatologia, São Paulo, v. 33, n. 3, p. 104-116, 2010.

CHINEN, Javier et al. Long-term follow-up of patients with primary immunodeficiencies. Journal Of Allergy And Clinical Immunology, [s.l.], v. 120, n. 4, p.795-797, out. 2007. Elsevier BV. http://dx.doi.org/10.1016/j.jaci.2007.07.044.

CONDINO-NETO, Antonio et al. Advancing the management of primary immunodeficiency diseases in Latin America: Latin American Society for Immunodeficiencies (LASID) Initiatives. Allergologia Et Immunopathologia, [s.l.], v. 40, n. 3, p.187-193, maio 2012. Elsevier BV. http://dx.doi.org/10.1016/j.aller.2012.01.003.

CONLEY, Mary Ellen et al. Primary B Cell Immunodeficiencies: Comparisons and Contrasts. Annual Review Of Immunology, [s.l.], v. 27, n. 1, p.199-227, abr. 2009. Annual Reviews. http://dx.doi.org/10.1146/annurev.immunol.021908.132649

CONLEY, Mary Ellen; STIEHM, Ewa Richard. Immunodeficiency disorders: general considerations. In: Stiehm Ewa Richard, editor. Immunologic disorders in infants and children. Philadelphia: W B Saunders, v. 4, n. 1, p. 201-249, 1996

CONLEY, Mary Ellen; NOTARANGELO, Luigi D.; ETZIONI, Amos. Diagnostic Criteria for Primary Immunodeficiencies. Clinical Immunology, [s.l.], v. 93, n. 3, p.190-197, dez. 1999. Elsevier BV. http://dx.doi.org/10.1006/clim.1999.4799.

EURORDIS. Undiagnosed rare diseases. 2019. Disponível em: https://www.eurordis.org/content/undiagnosed-rare-diseases. Acesso em: 2 fev. 2020.

EURORDIS. Rare Diseases: Understanding this Public Health Priority. 2005. Disponível em: https://www.eurordis.org/IMG/pdf/princeps_document-EN.pdf. Acesso em: 3 fev. 2020.

EURORDIS. Survey of the delay in diagnosis for 8 rare diseases in Europe. 2007. Disponível em: https://www.eurordis.org/sites/default/files/publications/Fact_Sheet_Eurordiscare2.pdf. Acesso em: 11 dez. 2020

GEHA, Raif S. et al. Primary immunodeficiency diseases: An update from the International Union of Immunological Societies Primary Immunodeficiency Diseases Classification Committee. Journal Of Allergy And Clinical Immunology, [s.l.], v. 120, n. 4, p.776-794, out. 2007. Elsevier BV. http://dx.doi.org/10.1016/j.jaci.2007.08.053.

GUPTA, Sudhir; LOUIS, Ankmalika Gupta. Tolerance and Autoimmunity in Primary Immunodeficiency Disease: a Comprehensive Review. Clinical Reviews In Allergy & Immunology, [s.l.], v. 45, n. 2, p.162-169, 9 jan. 2013. Springer Science and Business Media LLC. http://dx.doi.org/10.1007/s12016-012-8345-8.

IMMUNE DEFICIENCY FOUNDATION. Guide to Immunoglobulin Replacement Therapy for People Living with Primary Immunodeficiency Diseases. USA. 2018. Disponível em: https://primaryimmune.org/sites/default/files/publications/IDF%20Guide%20to%20Ig%20Therapy.pdf. Acesso em: 29 de março de 2021.

JEFFERIS, Roy; KUMARARATNE, Dinakantha S. Selective IgG subclass deficiency: quantification and clinical relevance. Clinical & Experimental Immunology, [s.l.], v. 81, n. 3, p.357-367, 28 jun. 2008. Wiley. http://dx.doi.org/10.1111/j.1365-2249.1990.tb05339.x.

KOLE, Anna; FAURISSON, François. Rare Diseases Social Epidemiology: Analysis of Inequalities. Rare Diseases Epidemiology, [s.l.], p.223-250, 2010. Springer Netherlands. http://dx.doi.org/10.1007/978-90-481-9485-8_14.

LUXEMBURGO. Comissão Europeia. Doenças raras: Os desafios da Europa. Direção Geral da Saúde e da Defesa do Consumidor. Disponível em: https://ec.europa.eu/health/archive/ph_threats/non_com/docs/raredis_comm_pt.pdf. Acesso em: 14 mar. 2020.

MOURA, Renata de Macedo. Itinerário diagnóstico e terapêutico das famílias e dos pacientes com doenças órfãs. 2013. 80 f. Dissertação (Mestrado) - Curso de Promoção da Saúde e Prevenção da Violência, Universidade Federal de Minas Gerais, Belo Horizonte, MG, 2013.

PALARETI, Laura et al. Shared topics on the experience of people with haemophilia living in the UK and the USA and the influence of individual and contextual variables: Results from the HERO qualitative study. International Journal Of Qualitative Studies On Health And Well-being, [s.l.], v. 10, n. 1, p.28915-28915, jan. 2015. Informa UK Limited. http://dx.doi.org/10.3402/qhw.v10.28915.

RAJASIMHA, Harsha Karur et al. Organization for rare diseases India (ORDI) – addressing the challenges and opportunities for the Indian rare diseases' community. Genetics Research, [s.l.], v. 96, p.1-10, 2014. Cambridge University Press (CUP). http://dx.doi.org/10.1017/s0016672314000111.

REINO UNIDO. SOCIAL VALUE UK. Rare Disease Impact Report: Insights from patients and the medical community. 2013. Disponível em: http://www.socialvalueuk.org/app/uploads/2017/03/ShireReport-1.pdf. Acesso em: 14 mar. 2020.

ROXO JÚNIOR, Pérsio et al. Infecções de repetição: o que é importante para o pediatra. Revista Paulista de Pediatria, [S.L.], v. 27, n. 4, p. 430-435, dez. 2009. FapUNIFESP (SciELO). http://dx.doi.org/10.1590/s0103-05822009000400013.

SHEHATA, Nadine et al. The Use of Immunoglobulin Therapy for Patients With Primary Immune Deficiency: an evidence-based practice guideline. Transfusion Medicine Reviews, [S.L.], v. 24, p. 28-50, jan. 2010. Elsevier BV. http://dx.doi.org/10.1016/j.tmrv.2009.09.011.

STIEHM, Ewa Richard. IgG subclass deficiencies. Immunologic Disorders in infants and children, v. 5, n.1, p 393-398, 2004. Elsevier BV.

WINKELSTEIN, Jerry A. et al. The X-Linked Hyper-IgM Syndrome: clinical and immunologic features of 79 patients. Medicine, [s.l.], v. 82, n. 6, p.373-384, nov. 2003. Ovid Technologies (Wolters Kluwer Health). http://dx.doi.org/10.1097/01.md.0000100046.06009.b0.

WORONIECKA, Monika; BALLOW, Mark. Office evaluation of children with recurrent infection. Pediatric Clinics Of North America, [s.l.], v. 47, n. 6, p.1211-1224, dez. 2000. Elsevier BV. http://dx.doi.org/10.1016/s0031-3955(05)70268-6

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.

Copyright (c) 2022 Serviço Social e Saúde

Downloads

Download data is not yet available.